Ferring Pharmaceuticals

This study tests a gene therapy (nadofaragene firadenovec) given directly into the bladder, alone or with chemotherapy or immunotherapy, for people with a high-grade bladder cancer that has not responded to standard BCG therapy. The goal is to see if the treatment can make the ca…

This early-stage trial tests a gene therapy drug called nadofaragene firadenovec, which is instilled directly into the kidney's drainage system. It aims to treat low-grade upper tract urothelial cancer (LG-UTUC) by delivering a gene that helps the body fight cancer cells. The stu…

This study tests a gene therapy called nadofaragene firadenovec against simply watching and waiting in people with intermediate-risk non-muscle invasive bladder cancer. About 454 participants will be randomly assigned to receive the treatment or be observed. The goal is to see if…

This study tests a medicine called CLENPIQ to clean the colon before a colonoscopy in children aged 2 to 8 years. About 30 children will receive the medicine, and doctors will check how well it cleans the colon and if it is safe. The goal is to make the bowel preparation process …

This study will follow about 2,500 Chinese women who are prescribed REKOVELLE for the first time during IVF or ICSI procedures. Researchers will observe how the drug is used in everyday practice and track key outcomes like live birth rates and side effects. The goal is to gather …